Kestra Medical Technologies, Ltd. Common Stock (KMTS) is a publicly traded Healthcare sector company. As of July 14, 2026, KMTS trades at $24.10 with a market cap of $1.45B and a P/E ratio of -4.72. KMTS moved -1.86% today. Year to date, KMTS is -8.82%; over the trailing twelve months it is +56.71%. Its 52-week range spans $13.25 to $30.00. Analyst consensus is buy with an average price target of $30.00. Rallies surfaces KMTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for KMTS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $24.10 |
| Market Cap | $1.45B |
| P/E Ratio | -4.72 |
| EPS | $-5.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $30.00 |
| 52-Week Low | $13.25 |
| Volume | 332.46K |
| Avg Volume | 0 |
| Revenue (TTM) | $59.81M |
| Net Income | $-113.81M |
| Gross Margin | 40.48% |
2 analysts cover KMTS: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $30.00.